Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, nausea on Wegovy is at its worst in the first one to two weeks after starting or increasing a dose, then fades noticeably over the following fortnight as the body adjusts. It rarely disappears overnight, but it does settle for the majority of patients. Wegovy (semaglutide) is a prescription-only medicine requiring clinical assessment before it can be prescribed — a GPhC-registered prescriber reviews every consultation at nume.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people on semaglutide worry that if the nausea feels bad, something has gone wrong, or that if it has passed, the medicine has stopped doing anything. Neither is quite right. Nausea is a predictable consequence of slowing gastric emptying (the rate at which your stomach moves food along), which is part of how semaglutide reduces appetite and calorie intake. The discomfort is a sign the medicine is doing something, not a sign of a problem, in the vast majority of cases.
The more useful question is how long that feeling lasts, and the honest answer is: it depends on the dose and the individual, but there is a clear pattern. According to NHS guidance on semaglutide, nausea is a very common side effect, particularly in the early weeks. It tends to be sharpest in the first week or two after each dose increase, then softens. Most people find it is manageable by week three or four at that dose level.
Once you reach a maintenance dose and stay there, many people find nausea largely stops being part of daily life. The slow titration ladder (rising from 0.25mg through 0.5mg, 1.0mg, 1.7mg, to 2.4mg in roughly four-week steps) is designed specifically to reduce this impact. Moving too fast is one of the most common reasons nausea becomes difficult to tolerate. That is a clinical decision worth discussing before your next dose step.
The first few weeks are, for many people, the hardest. At the starting dose, the stomach is adjusting to a new pattern of emptying, and nausea can arrive within hours of an injection and linger through much of the day. That initial intensity typically eases over one to two weeks. Some people feel fine by day five; others need closer to a fortnight. Both are within the normal range.
After dose increases, the same pattern tends to repeat, a short, sharper window of queasiness that settles as the body recalibrates. By the time someone reaches the 2.4mg maintenance dose, many find they have already built up a working tolerance to semaglutide's GI effects. Nausea at maintenance is less common than at the start, though some people experience occasional flare-ups, particularly after eating large or high-fat meals, which can intensify the gastric-slowing effect.
Timing of the injection matters too. Many people find switching to a time when they are less likely to eat a large meal shortly afterwards (or taking the injection before bed) changes the experience considerably. There is more practical guidance on techniques like these in our Wegovy nausea management guide. Nausea that is severe enough to prevent eating or drinking for more than a day or two, or that feels qualitatively different from earlier weeks, is worth flagging to a prescriber rather than pushing through.
Most nausea on Wegovy is mild to moderate and resolves without intervention. A smaller number of people experience vomiting alongside it; our page on how long vomiting lasts on Wegovy covers that pattern specifically. Diarrhoea can also accompany the early weeks of treatment, and the picture for that side effect is broadly similar in its time course.
There are signs that should prompt you to seek medical help promptly rather than waiting it out. Severe stomach pain that does not ease (especially pain that radiates through to your back, with or without vomiting) should not be attributed to ordinary sickness. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines noting that acute pancreatitis is a known but uncommon side effect requiring urgent assessment. You can find the full update via the MHRA's Drug Safety Update index. Signs of significant dehydration (dizziness, reduced urination, confusion) from prolonged vomiting or diarrhoea also warrant urgent contact with a healthcare professional.
If you experience a symptom that concerns you and you are unsure whether it needs immediate attention, contacting our team via the support page is a reasonable first step, we offer priority aftercare seven days a week. For anything that feels urgent, NHS 111 or your GP is always the right route.
A separate but related question is whether nausea can appear or persist after treatment ends. For most people, stopping semaglutide means GI symptoms resolve relatively quickly as gastric emptying returns toward its pre-treatment rate. There is a fuller look at what that process involves on our page covering how long nausea lasts after stopping Wegovy.
The broader overview of Wegovy side effects covers the full picture of what to expect and how each typically behaves over time. If you are considering Wegovy or want to understand how the titration schedule might work for your situation, our prescribers discuss all of this as part of a free consultation, not after you have committed to anything. Wegovy is a prescription-only medicine, and whether it is clinically appropriate for you is a decision made with a qualified prescriber, not before one. You can start that conversation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.